Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
25,600
0.00 (0.00%)
At close: Mar 26, 2025, 3:30 PM KST
-9.86%
Market Cap 149.35B
Revenue (ttm) 204.19B
Net Income (ttm) 33.76B
Shares Out 5.88M
EPS (ttm) 5,741.00
PE Ratio 4.42
Forward PE n/a
Dividend 750.00 (2.95%)
Ex-Dividend Date Dec 27, 2024
Volume 15,916
Average Volume 9,327
Open 25,550
Previous Close 25,600
Day's Range 25,500 - 25,900
52-Week Range 23,750 - 29,350
Beta 0.17
RSI 44.05
Earnings Date Mar 21, 2025

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2024, Daihan Pharmaceutical's revenue was 204.19 billion, an increase of 4.23% compared to the previous year's 195.91 billion. Earnings were 33.76 billion, an increase of 18.76%.

Financial Statements

News

There is no news available yet.